Cardiac steatosis potentiates angiotensin II effects in the heart

Denis J. Glenn, Michelle C. Cardema, Wei Ni, Yan Zhang, Yerem Yeghiazarians, Dmitry Grapov, Oliver Fiehn, David G. Gardner

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Lipid accumulation in the heart is associated with obesity and diabetes and may play an important role in the pathogenesis of heart failure. The renin-angiotensin system is also thought to contribute to cardiovascular morbidity in obese and diabetic patients. We hypothesized that the presence of lipid within the myocyte might potentiate the cardiomyopathic effects of ANG II in the cardiac diacylglycerol acyl transferase 1 (DGAT1) transgenic mouse model of myocyte steatosis. Treatment with ANG II resulted in a similar increase in blood pressure in both nontransgenic and DGAT1 transgenic mice. However, ANG II in DGAT1 transgenic mice resulted in a marked increase in interstitial fibrosis and a reduction in systolic function compared with nontransgenic littermates. Lipidomic analysis revealed that >20% of lipid species were significantly altered between nontransgenic and DGAT1 transgenic animals, whereas 3% were responsive to ANG II administration. ROS were also increased by ANG II in DGAT1 transgenic hearts. ANG II treatment resulted in increased expression of transforming growth factor (TGF)-β2 and the type I TGF-β receptor as well as increased phosphorylation of Smad2 in DGAT1 transgenic hearts. Injection of neutralizing antibodies to TGF-β resulted in a reduction in fibrosis in DGAT1 transgenic hearts treated with ANG II. These results suggest that myocyte steatosis amplifies the fibrotic effects of ANG II through mechanisms that involve activation of TGF-β signaling and increased production of ROS.

Original languageEnglish (US)
Pages (from-to)H339-H350
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume308
Issue number4
DOIs
StatePublished - Feb 15 2015

Fingerprint

Diglycerides
Transferases
Angiotensin II
Transforming Growth Factors
Muscle Cells
Transgenic Mice
Lipids
Fibrosis
Genetically Modified Animals
Growth Factor Receptors
Renin-Angiotensin System
Neutralizing Antibodies
Heart Failure
Obesity
Phosphorylation
Blood Pressure
Morbidity
Injections
Therapeutics

Keywords

  • Angiotensin
  • Diacylglycerol acyl transferase 1
  • Fibrosis
  • Lipotoxixity
  • Transforming growth factor-β

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Glenn, D. J., Cardema, M. C., Ni, W., Zhang, Y., Yeghiazarians, Y., Grapov, D., ... Gardner, D. G. (2015). Cardiac steatosis potentiates angiotensin II effects in the heart. American Journal of Physiology - Heart and Circulatory Physiology, 308(4), H339-H350. https://doi.org/10.1152/ajpheart.00742.2014

Cardiac steatosis potentiates angiotensin II effects in the heart. / Glenn, Denis J.; Cardema, Michelle C.; Ni, Wei; Zhang, Yan; Yeghiazarians, Yerem; Grapov, Dmitry; Fiehn, Oliver; Gardner, David G.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 308, No. 4, 15.02.2015, p. H339-H350.

Research output: Contribution to journalArticle

Glenn, DJ, Cardema, MC, Ni, W, Zhang, Y, Yeghiazarians, Y, Grapov, D, Fiehn, O & Gardner, DG 2015, 'Cardiac steatosis potentiates angiotensin II effects in the heart', American Journal of Physiology - Heart and Circulatory Physiology, vol. 308, no. 4, pp. H339-H350. https://doi.org/10.1152/ajpheart.00742.2014
Glenn, Denis J. ; Cardema, Michelle C. ; Ni, Wei ; Zhang, Yan ; Yeghiazarians, Yerem ; Grapov, Dmitry ; Fiehn, Oliver ; Gardner, David G. / Cardiac steatosis potentiates angiotensin II effects in the heart. In: American Journal of Physiology - Heart and Circulatory Physiology. 2015 ; Vol. 308, No. 4. pp. H339-H350.
@article{e42872b8542b475393782d450408d01a,
title = "Cardiac steatosis potentiates angiotensin II effects in the heart",
abstract = "Lipid accumulation in the heart is associated with obesity and diabetes and may play an important role in the pathogenesis of heart failure. The renin-angiotensin system is also thought to contribute to cardiovascular morbidity in obese and diabetic patients. We hypothesized that the presence of lipid within the myocyte might potentiate the cardiomyopathic effects of ANG II in the cardiac diacylglycerol acyl transferase 1 (DGAT1) transgenic mouse model of myocyte steatosis. Treatment with ANG II resulted in a similar increase in blood pressure in both nontransgenic and DGAT1 transgenic mice. However, ANG II in DGAT1 transgenic mice resulted in a marked increase in interstitial fibrosis and a reduction in systolic function compared with nontransgenic littermates. Lipidomic analysis revealed that >20{\%} of lipid species were significantly altered between nontransgenic and DGAT1 transgenic animals, whereas 3{\%} were responsive to ANG II administration. ROS were also increased by ANG II in DGAT1 transgenic hearts. ANG II treatment resulted in increased expression of transforming growth factor (TGF)-β2 and the type I TGF-β receptor as well as increased phosphorylation of Smad2 in DGAT1 transgenic hearts. Injection of neutralizing antibodies to TGF-β resulted in a reduction in fibrosis in DGAT1 transgenic hearts treated with ANG II. These results suggest that myocyte steatosis amplifies the fibrotic effects of ANG II through mechanisms that involve activation of TGF-β signaling and increased production of ROS.",
keywords = "Angiotensin, Diacylglycerol acyl transferase 1, Fibrosis, Lipotoxixity, Transforming growth factor-β",
author = "Glenn, {Denis J.} and Cardema, {Michelle C.} and Wei Ni and Yan Zhang and Yerem Yeghiazarians and Dmitry Grapov and Oliver Fiehn and Gardner, {David G.}",
year = "2015",
month = "2",
day = "15",
doi = "10.1152/ajpheart.00742.2014",
language = "English (US)",
volume = "308",
pages = "H339--H350",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "4",

}

TY - JOUR

T1 - Cardiac steatosis potentiates angiotensin II effects in the heart

AU - Glenn, Denis J.

AU - Cardema, Michelle C.

AU - Ni, Wei

AU - Zhang, Yan

AU - Yeghiazarians, Yerem

AU - Grapov, Dmitry

AU - Fiehn, Oliver

AU - Gardner, David G.

PY - 2015/2/15

Y1 - 2015/2/15

N2 - Lipid accumulation in the heart is associated with obesity and diabetes and may play an important role in the pathogenesis of heart failure. The renin-angiotensin system is also thought to contribute to cardiovascular morbidity in obese and diabetic patients. We hypothesized that the presence of lipid within the myocyte might potentiate the cardiomyopathic effects of ANG II in the cardiac diacylglycerol acyl transferase 1 (DGAT1) transgenic mouse model of myocyte steatosis. Treatment with ANG II resulted in a similar increase in blood pressure in both nontransgenic and DGAT1 transgenic mice. However, ANG II in DGAT1 transgenic mice resulted in a marked increase in interstitial fibrosis and a reduction in systolic function compared with nontransgenic littermates. Lipidomic analysis revealed that >20% of lipid species were significantly altered between nontransgenic and DGAT1 transgenic animals, whereas 3% were responsive to ANG II administration. ROS were also increased by ANG II in DGAT1 transgenic hearts. ANG II treatment resulted in increased expression of transforming growth factor (TGF)-β2 and the type I TGF-β receptor as well as increased phosphorylation of Smad2 in DGAT1 transgenic hearts. Injection of neutralizing antibodies to TGF-β resulted in a reduction in fibrosis in DGAT1 transgenic hearts treated with ANG II. These results suggest that myocyte steatosis amplifies the fibrotic effects of ANG II through mechanisms that involve activation of TGF-β signaling and increased production of ROS.

AB - Lipid accumulation in the heart is associated with obesity and diabetes and may play an important role in the pathogenesis of heart failure. The renin-angiotensin system is also thought to contribute to cardiovascular morbidity in obese and diabetic patients. We hypothesized that the presence of lipid within the myocyte might potentiate the cardiomyopathic effects of ANG II in the cardiac diacylglycerol acyl transferase 1 (DGAT1) transgenic mouse model of myocyte steatosis. Treatment with ANG II resulted in a similar increase in blood pressure in both nontransgenic and DGAT1 transgenic mice. However, ANG II in DGAT1 transgenic mice resulted in a marked increase in interstitial fibrosis and a reduction in systolic function compared with nontransgenic littermates. Lipidomic analysis revealed that >20% of lipid species were significantly altered between nontransgenic and DGAT1 transgenic animals, whereas 3% were responsive to ANG II administration. ROS were also increased by ANG II in DGAT1 transgenic hearts. ANG II treatment resulted in increased expression of transforming growth factor (TGF)-β2 and the type I TGF-β receptor as well as increased phosphorylation of Smad2 in DGAT1 transgenic hearts. Injection of neutralizing antibodies to TGF-β resulted in a reduction in fibrosis in DGAT1 transgenic hearts treated with ANG II. These results suggest that myocyte steatosis amplifies the fibrotic effects of ANG II through mechanisms that involve activation of TGF-β signaling and increased production of ROS.

KW - Angiotensin

KW - Diacylglycerol acyl transferase 1

KW - Fibrosis

KW - Lipotoxixity

KW - Transforming growth factor-β

UR - http://www.scopus.com/inward/record.url?scp=84982746736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84982746736&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00742.2014

DO - 10.1152/ajpheart.00742.2014

M3 - Article

C2 - 25485904

AN - SCOPUS:84982746736

VL - 308

SP - H339-H350

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 4

ER -